超快速玻璃化与快速洗脱人卵母细胞:第二部分——成熟卵母细胞囊胚发育的验证
本研究比较超快速玻璃化(UFV)与常规玻璃化对成熟人卵母细胞的保存效果。UFV组存活率94-100%(均值98%)高于常规组80-90%(均值83.3%)(P=0.003)。两组均能正常激活发育并形成囊胚(34.9% vs 31.7%),UFV更省时且存活率更高。
要点
- UFV/快速洗脱组卵母细胞存活率94-100%(均值98%),高于常规玻璃化/对照稀释组的80-90%(均值83.3%)(P=0.003)。
- 成熟卵母细胞经UFV或常规玻璃化后均能正常激活发育并产生囊胚,形成率分别为34.9%和31.7%。
- UFV是更省时的卵母细胞冷冻方法,存活率更高,有潜力产生更多胚胎。
核心结论
- UFV方法与传统半平衡玻璃化方案有策略性差异,更省时且持续获得更高存活率,因此有潜力产生更多胚胎。
- 这些发现支持开展策略性临床试验申请。
研究设计与样本
- 研究比较常规玻璃化与UFV处理成熟人卵母细胞的效果。
- 样本包括生发泡来源的成熟卵母细胞(第2阶段,实验2,n=50)和次标准供者卵母细胞、中期I-中期II(MII)卵母细胞及低质量MII卵母细胞(n=222)。
- 评估指标包括复温后存活率、减数分裂纺锤体完整性和人工卵母细胞激活(AOA)相关发育。
主要发现
- UFV/快速洗脱组总存活率94-100%(均值98%),常规玻璃化/对照稀释组80-90%(均值83.3%),UFV组更高(P=0.003)。
- 来自未成熟生发泡的MII卵母细胞经常规玻璃化/对照稀释或UFV/快速洗脱处理后能够激活发育(卵裂率54-71%),共产生4个囊胚。
- 使用DMAP暴露的AOA处理获得最佳激活发育。
- 玻璃化成熟卵母细胞时,UFV和常规玻璃化均表现出正常的激活发育和囊胚产生(分别为34.9%和31.7%)。
临床怎么用
- 作者认为UFV方法更省时且持续获得更高存活率,有潜力产生更多胚胎。
- 作者认为这些发现支持开展策略性临床试验申请。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Will ultra-fast vitrification (UFV) and rapid elution of mature human oocytes retain the reliable, high survival rates and meiotic spindle normality seen in the germinal vesicle model, and will these oocytes maintain their developmental competence to form blastocyst-stage embryos following artificial oocyte activation (AOA)? DESIGN: Conventional vitrification treatment was compared with UFV treatment in mature, germinal-vesicle-derived oocytes (Phase 2, Expt. 2, n = 50) and substandard donor oocytes, metaphase I-metaphase II (MII) oocytes and poor-quality MII oocytes (n = 222). Post-warming survival, the integrity of the meiotic spindle and AOA-related development were assessed. RESULTS: Overall survival rates were higher (P = 0.003) for UFV/rapid elution treatment (94-100%, mean = 98%) compared with conventional vitrification/control dilution treatment (80-90%, mean = 83.3%). MII oocytes derived from immature germinal vesicles following conventional vitrification/control dilution or UFV/rapid elution treatments proved to be capable of activated development (54-71% cleavage rate), with four blastocysts produced. AOA treatment with DMAP exposure yielded optimal activated development. When vitrifying mature oocytes, both UFV and conventional vitrification treatments exhibited normal activated development and blastocyst production (34.9% and 31.7%, respectively). CONCLUSIONS: Considering that oocyte freezing was deemed non-experimental based primarily on healthy live births from frozen-oocyte-derived embryo transfer the validation of normal blastocyst formation using the novel UFV approach is a critical accomplishment. The UFV method for oocyte cryopreservation represents a strategic deviation from traditional semi-equilibration vitrification protocols. UFV is a more time-efficient approach that consistently yields a higher survival rate, and thus has the potential to create more embryos. These findings justify proceeding with strategic clinical trial applications.
引用
- Wozniak K, Reichelderfer R, Ghaemi S, et al. Ultra-fast vitrification and rapid elution of human oocytes: Part II - verification of blastocyst development from mature oocytes. Reprod Biomed Online. 2024. PMID: 39510915. doi:10.1016/j.rbmo.2024.104690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。